Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Pricing Pressures On Generics And Biosimilars Risk Killing Industry –EGA Execs

Executive Summary

New EGA president and director general say Europe must end downward pricing pressures on generic medicines manufacturers or risk losing that industry altogether.

Advertisement

Related Content

Can European Efficiency Measures Boost Generics And Biosimilars? – An Interview With EGA’s Adrian van den Hoven
Industry Sees Harmonization Opportunities In High-level U.S.-EU Trade Talks
Greece, Slashing Drug Budget Via Cuts And Non-Payment, Backs Generics
AstraZeneca Blames Germany’s Tender System For Influenza Vaccine Shortages
EU Pharmacovigilance Fees Could Cripple Drug Firms, Says Pharma Industry
European Regulatory Round-Up: Patents, Pricing And Parabens
Germany's Discount Contracts Are Changing The Pharma Market Landscape

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS055719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel